Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 49Gastrointestinal 43Genitourinary 41Gynecologic 27Other 24Head & Neck 21Thoracic 20CNS 15Other hematologic neoplasm 11Lymphoid 11Dermatologic 8Tumor-Agnostic 7Sarcoma 6Other solid neoplasm 5Plasma cell 3Endocrine 3NET 2Classical hematology 2Other neoplasm 1

Conditions

Hormone Receptor Positive Malignant Neoplasm of Breast 1

Interventions

Cyclophosphamide 13Peripheral Blood Stem Cell Transplantation 9Biopsy 9fludarabine phosphate 8Busulfan 8Whole-Body Irradiation 7Surveys and Questionnaires 6Mycophenolic Acid 6Educational Status 6Early Intervention, Educational 6Carboplatin 6fludarabine 5Tacrolimus 5Paclitaxel 5Methotrexate 5Methods 5Melphalan 5Epoetin Alfa 5Decitabine 5Cyclosporine 5Colposcopy 5Cisplatin 5Celecoxib 5Antilymphocyte Serum 5Aminolevulinic Acid 5Sulindac 4Selenium 4Radiotherapy 4Patient Reported Outcome Measures 4Magnetic Resonance Spectroscopy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Metformin × Other neoplasm × Clear all
NCT01589367 2018-09-10

Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer

Seoul National University Hospital

Phase 2 Completed
208 enrolled
BreastOther neoplasm

Hormone Receptor Positive Malignant Neoplasm of Breast

Data powered by HemOnc (CC BY 4.0) Colophon âš¡